Avoro Capital Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,050,000
| Closed | -$317M | – | 50 |
|
|
2023
Q2 | $317M | Buy |
8,050,000
+1,250,000
| +18% | +$49.2M | 4.3% | 11 |
|
|
2023
Q1 | $165M | Buy |
6,800,000
+50,000
| +0.7% | +$1.22M | 2.45% | 14 |
|
|
2022
Q4 | $145M | Buy |
6,750,000
+850,000
| +14% | +$18.2M | 2.16% | 14 |
|
|
2022
Q3 | $106M | Sell |
5,900,000
-1,220,000
| -17% | -$21.9M | 1.96% | 14 |
|
|
2022
Q2 | $68.5M | Sell |
7,120,000
-130,000
| -2% | -$1.25M | 1.35% | 18 |
|
|
2022
Q1 | $122M | Hold |
7,250,000
| – | – | 2.23% | 16 |
|
|
2021
Q4 | $121M | Buy |
7,250,000
+150,000
| +2% | +$2.51M | 2.06% | 13 |
|
|
2021
Q3 | $115M | Buy |
7,100,000
+675,000
| +11% | +$11M | 1.81% | 15 |
|
|
2021
Q2 | $40.5M | Sell |
6,425,000
-825,000
| -11% | -$5.21M | 0.71% | 28 |
|
|
2021
Q1 | $44.8M | Hold |
7,250,000
| – | – | 0.77% | 27 |
|
|
2020
Q4 | $50.1M | Hold |
7,250,000
| – | – | 0.86% | 23 |
|
|
2020
Q3 | $40.9M | Buy |
7,250,000
+150,000
| +2% | +$846K | 0.58% | 26 |
|
|
2020
Q2 | $36.2M | Buy |
+7,100,000
| New | +$36.2M | 0.72% | 28 |
|